Roic AI
Solutions
API Docs
MCP
Pricing
Discord
Resources
Toggle navigation menu
Company Search
⌘
K
Toggle theme
Toggle theme
Login
Sign up
FSD Pharma Inc.
C
CSE:HUGE
Canadian Securities Exchange
- -
CAD
- -
- -
ISIN
CA35954B4047
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Use logarithmic scale
Customize view
USD
2015 Y
2016 Y
2017 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
- -
- -
- -
0.2
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.32
-0.29
-0.19
-27.75
-183.53
-360.45
-171.62
-65.63
-39.62
-29.39
-12.09
Free Cash Flow per Basic Share
- -
-0.27
-0.21
-61.44
-182.02
-132.78
-103.25
-39.52
-48.16
-17.78
-8.32
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.99
-2.3
-2.58
69.3
336.29
135.13
66.59
48.68
-1.26
-33.05
-35.95
Tangible Book Value per Share
-0.58
-0.54
-0.75
97.74
412.42
179.23
123.5
70.55
31.05
12.4
8.18
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
-13,585.61
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
2
4
4
5
3
1
Net Income, GAAP
- -
- -
- -
-3
-17
-39
-32
-35
-24
-18
-7
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-13,585.61
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
3
15
2
21
37
10
7
5
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
10
37
36
36
54
31
13
10
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
-88.81
-173.06
-235.48
-183.26
- -
- -
- -
Capital Structure
USD
•
in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
- -
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
47
38
9
Working Capital
USD
•
in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
11
9
10
Cash, Cash Equivalents & STI
4
2
3
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
4
5
Payables & Accruals
4
3
4
ST Debt
- -
1
1
Deferred Revenue
- -
- -
- -
Growth Rates
USD
•
in mil. unless spec.
(avg. rate of change)
10 years
5 years
1 year
Total Equity
- -
-11.06%
-57.73%
Free Cash Flow
- -
0.75%
-62.27%
Net Income, GAAP
- -
13.93%
-24.17%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -
Quarterly Revenue
USD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Quarterly Earnings Per Share
USD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2022
-9.6
-7.47
-12.13
- -
-39.62
2023
-16.61
-9.1
-1.88
- -
-29.39
2024
-3.12
-4.85
- -
- -
- -
Quarterly Dividends Per Share
USD
•
in mil. unless spec.
Year
Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Company Description
Company Profile API
ChatGPT
Google Sheets
Address
Similar Companies
Business
Toronto
London
Frankfurt
Dubai
Mumbai
Hong Kong
Seoul
Tokyo
Unlock non-US companies
Get Access
Already premium?
Sign in
Summary
Financials
Ratios
Charts
Classic View
Statistics
Stock Splits
Stock Prices API
ChatGPT
Google Sheets